A recent study raises red flags about compounded tirzepatide (the GLP-1 agonist in Zepbound and Mounjaro) mixed with vitamin B-12
examined this concept in obese patients who lost weight and were maintained at 10% below their initial weight (see the related article beginning on page 2583)
I feel lighter, more focused, and in control of my appetite
Cardiovascular risk markersincluding blood pressure, C-reactive protein, and atherosclerotic burdenalso inform provider recommendations
In the retinas of diabetic mice treated with GLP-1RAs, a significant elevation in both cAMP and pAKT levels was observed, indicating successful target engagement and triggering of downstream pro-survival signals [36]
Its a staggering statistic, and one worth remembering as a nutritionist